For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
This week in health care policy: October 31-November 6, 2026
Drug pricing and PBMs Medicare’s second round of negotiated prices starts in two months. On January 1, negotiated prices for…
Blog
This week in health care policy: October 24-30, 2026
FDA and innovation FDA and CMS move on personalized gene therapies. The FDA released draft guidance that lets developers of…
Blog
Market-oriented reforms that can save Medicare $100 billion
Since 1970, Medicare spending has grown from 0.7 percent of GDP to 4.0 percent of GDP, and it is projected to grow even further.
Search Posts
Products
A Real Bill Of Rights For Passengers
Well, the sure signs of summer are upon us once again. The temperature is rising, there are tourists everywhere, and things are slowing down to…
News Release
CEI Weighs In On Drycleaning Zoning Proposal
<?xml:namespace prefix = o ns = “urn:schemas-microsoft-com:office:office” /> TESTIMONY OF THE COMPETITIVE ENTERPRISE INSTITUTE…
News Release
CEI Comments Before FDA on Bioengineered Foods
COMMENTS OF THE COMMENTS OF THE COMPETITIVE ENTERPRISE INSTITUTE TO THE FOOD AND DRUG ADMINISTRATION REGARDING THE…
Products
Hope, Not Hype, in the Golden Grains
Two years ago, practically no one had ever heard of Ingo Potrykus Two years ago, practically no one had ever heard of…
Op-Eds
Designer Jeans from Designer Genes: Henry Miller National Post Op-Ed
California Gov Published February 12, 2001 The National Post (Canada) Self-styled environmentalists have been virtually unanimous in opposing biotechnology,…
Op-Eds
FDA Fails to Give Olestra Fair Weight: Henry Miller LA Times Op-Ed
Published in the Los Angeles Times Published in the Los Angeles Times February 4, 2001 The sad…